Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study
- PMID: 11739980
- DOI: 10.1161/hs1201.99821
Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: a case-control study
Abstract
Background and purpose: The relationship between arterial recanalization, infarct size, and outcome in patients treated with intravenous thrombolytics remains unclear. Therefore, we aimed to determine the time course of recombinant tissue plasminogen activator (rtPA)-induced recanalization in patients with cardioembolic stroke treated <3 hours from symptom onset and to investigate the relationship between arterial recanalization, infarct volume, and outcome.
Methods: We prospectively studied 72 patients with an acute cardioembolic stroke in the middle cerebral artery territory: 24 treated with rtPA at <3 hours and 48 matched controls. Serial transcranial Doppler examinations were performed on admission and at 6,12, 24, and 48 hours. Infarct volume was measured by use of CT at day 5 to 7. Modified Rankin Scale score was used to assess outcome at 3 months.
Results: Rate of 6-hour recanalization was higher (P<0.001) in the rtPA group (66%) than in the control group (15%). Five (20.8%) rtPA patients and 15 (31.2%) controls recanalized between 6 and 12 hours, and 2 (8.3%) patients and 12 (25%) controls between 12 and 48 hours, respectively. At 48 hours, 75% of rtPA patients and 27% of controls had improved (P<0.001). Infarct volume was 50.2+/-40.3 cm(3) in rtPA patients and 124.8+/-81.6 cm(3) in controls (P<0.001). Moreover, infarct volume was associated strongly (P<0.001) with duration of middle cerebral artery occlusion. At 3 months, 14 (58%) rtPA patients and 11 (23%) controls (P=0.037) became functionally independent (modified Rankin Scale score </=2). A close relationship (P=0.002) existed between modified Rankin Scale score at 3 months and time to reperfusion. In addition, clinical outcome was associated strongly (P=0.001) with degree of 6-hour recanalization. Logistic regression analysis identified National Institutes of Health Stroke Scale score <17 (odds ratio 12.1, 95% confidence interval 2.8 to 68, P=0.001) and early recanalization (odds ratio 23.4, 95% confidence interval 5.4 to 96, P=0.001) as independent predictors of functional independence at 3 months.
Conclusions: Intravenous rtPA is associated with early recanalization, which leads to lower infarct size and better clinical outcome. Early recanalization is a powerful independent predictor of functional independence at 3 months.
Similar articles
-
Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion.Stroke. 2002 Jun;33(6):1551-6. doi: 10.1161/01.str.0000016323.13456.e5. Stroke. 2002. PMID: 12052990 Clinical Trial.
-
Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.Stroke. 2004 Jan;35(1):151-6. doi: 10.1161/01.STR.0000106485.04500.4A. Epub 2003 Dec 11. Stroke. 2004. PMID: 14671245 Clinical Trial.
-
Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.Stroke. 2003 May;34(5):1235-41. doi: 10.1161/01.STR.0000068406.30514.31. Epub 2003 Apr 3. Stroke. 2003. PMID: 12677014
-
Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?Stroke. 2002 May;33(5):1437-41. doi: 10.1161/01.str.0000015555.21285.db. Stroke. 2002. PMID: 11988629 Review.
-
Meta-analysis of Vascular Imaging Features to Predict Outcome Following Intravenous rtPA for Acute Ischemic Stroke.Front Neurol. 2016 May 18;7:77. doi: 10.3389/fneur.2016.00077. eCollection 2016. Front Neurol. 2016. PMID: 27242660 Free PMC article. Review.
Cited by
-
Does the sex of acute stroke patients influence the effectiveness of rt-PA?BMC Neurol. 2014 Mar 26;14:60. doi: 10.1186/1471-2377-14-60. BMC Neurol. 2014. PMID: 24669960 Free PMC article. Clinical Trial.
-
Reperfusion therapy for acute stroke improves outcome by decreasing neuroinflammation.Transl Stroke Res. 2010 Dec;1(4):261-7. doi: 10.1007/s12975-010-0038-0. Epub 2010 Aug 28. Transl Stroke Res. 2010. PMID: 24323553
-
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke.Med J Islam Repub Iran. 2013 Aug;27(3):113-8. Med J Islam Repub Iran. 2013. PMID: 24791120 Free PMC article.
-
Prognostic Value of Cerebral Hemodynamics Assessment on 24-h Transcranial Color-Coded Doppler Following a Successful Thrombectomy.Eur J Neurol. 2025 Jun;32(6):e70224. doi: 10.1111/ene.70224. Eur J Neurol. 2025. PMID: 40439468 Free PMC article.
-
Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study.BMC Neurol. 2022 Jul 27;22(1):280. doi: 10.1186/s12883-022-02808-w. BMC Neurol. 2022. PMID: 35897006 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical